Pfizer forecasts 2025 profit in line with expectations
Reuters12-17
Pfizer forecasts 2025 profit in line with expectationsDec 17 (Reuters) - Drugmaker Pfizer PFE.N on Tuesday said it was expecting its 2025 profits to be roughly in line with Wall Street expectations as it seeks to fend off criticism over its turnaround strategy from activist hedge fund Starboard Value.
The company expects adjusted profit per share of $2.80 to $3.00, compared with analysts' average estimate of $2.88 per share, according to data compiled by LSEG.
(Reporting by Mariam Sunny and Manas Mishra; Editing by Anil D'SilvaBengaluru)
((Mariam.ESunny@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
